Novo Nordisk parent buys US drug firm for $16.5bn to expand Wegovy supply | Pharmaceuticals industry
The explosion in demand for the weight-loss drug Wegoby has prompted the holding company of its maker, Novo Nordisk, to buy the US-based drug giant for $16.5 billion ($12.70) and end its production capacity. Novo Holdings has acquired New Jersey-based pharmaceutical company Catalent, which it plans to immediately sell three of its locations in the […]